You have 9 free searches left this month | for more free features.

gemcitabine

Showing 1 - 25 of 1,024

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Cancer, Breast Tumors Trial in Charlottesville (drug, device, other)

Recruiting
  • Breast Cancer
  • Breast Neoplasms
  • Gemcitabine
  • +2 more
  • Charlottesville, Virginia
    University of Virginia
May 17, 2022

Pancreatic Cancer Trial (Adavosertib, Gemcitabine)

Withdrawn
  • Pancreatic Cancer
  • (no location specified)
Jun 10, 2022

Nasopharyngeal Carcinoma, Recurrent or Metastatic Trial in Beijing (KL-A167, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Recurrent or Metastatic
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 23, 2022

Urinary Bladder Cancer Trial in Tucson (Gemcitabine)

Not yet recruiting
  • Urinary Bladder Cancer
  • Gemcitabine
  • Tucson, Arizona
    University of Arizona Cancer Center
Dec 21, 2022

Malignant Pleural Mesothelioma Trial in Cairo (Gemcitabine, supportive care)

Not yet recruiting
  • Malignant Pleural Mesothelioma
  • Gemcitabine
  • supportive care
  • Cairo, Egypt
    Ain Shams University Hospital
Dec 20, 2022

Pancreas Cancer Trial in Houston (Gemcitabine, Nab paclitaxel, IM156)

Not yet recruiting
  • Pancreas Cancer
  • Gemcitabine
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 15, 2022

Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Resectable Pancreatic Cancer
  • Nab paclitaxel
  • +2 more
  • (no location specified)
Dec 5, 2022

Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable Trial in Hannover (Durvalumab, Gemcitabine,

Active, not recruiting
  • Cholangiocarcinoma
  • +3 more
  • Durvalumab
  • +3 more
  • Hannover, Germany
    Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
Oct 14, 2021

Sarcoma Trial in Santa Monica (Gemcitabine, Doxorubicin, Docetaxel)

Recruiting
  • Sarcoma
  • Gemcitabine
  • +3 more
  • Santa Monica, California
    Sant P Chawla
May 4, 2022

Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,

Not yet recruiting
  • Pancreatic Cancer, Stage IB
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Jan 4, 2023

Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)

Recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 17, 2022

Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 21, 2022

Cervical Carcinoma Trial in La Jolla (Intensity Modulated Radiation Therapy (IMRT), Cisplatin, Gemcitabine)

Completed
  • Cervical Carcinoma
  • Intensity Modulated Radiation Therapy (IMRT)
  • +2 more
  • La Jolla, California
    Moores UC San Diego Cancer Center
Feb 16, 2022

Pancreatic Tumors Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Neoplasms
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 10, 2022

Pancreatic Cancer, Pancreas Cancer, Pancreatic Adenocarcinoma Resectable Trial in Scottsdale (Ascorbic Acid, Paclitaxel

Completed
  • Pancreatic Cancer
  • +4 more
  • Ascorbic Acid
  • +3 more
  • Scottsdale, Arizona
    HonorHealth Research Institute
Feb 10, 2022

Advanced Biliary Tract Cancer Trial in Guangzhou (Envofolimab, Lenvatinib, Gemcitabine)

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 9, 2022

Urothelial Carcinoma Bladder, PD-1 Inhibitor Trial in Shanghai (Tislelizumab, Gemcitabine, Cisplatin)

Recruiting
  • Urothelial Carcinoma Bladder
  • PD-1 Inhibitor
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Aug 15, 2022

Diffuse Intrinsic Pontine Glioma Trial in Aurora (Gemcitabine)

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Gemcitabine
  • Aurora, Colorado
    Children's Hospital Colorado
Jan 31, 2022

Ewing Sarcoma, Ewing-Like Sarcoma Trial in New York (LY2880070, Gemcitabine)

Recruiting
  • Ewing Sarcoma
  • Ewing-Like Sarcoma
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Apr 26, 2022

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Beverly Hills, Los Angeles

Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Gemcitabine
  • +2 more
  • Beverly Hills, California
  • +1 more
Jun 16, 2022

Mature T-Cell and NK-Cell Tumor Trial in Hwasun-gun (Copanlisib, Gemcitabine)

Completed
  • Mature T-Cell and NK-Cell Neoplasm
  • Hwasun-gun, Jeollanam-do, Korea, Republic of
    Chonnam National University Hwasun Hospital
Jun 9, 2022

Non-muscle-invasive Bladder Cancer Trial in Cairo (BCG, Gemcitabine)

Recruiting
  • Non-muscle-invasive Bladder Cancer
  • Cairo, Egypt
    Mohamed Fawzy Salman
Nov 19, 2022

Pancreatic Ductal Adenocarcinoma Trial in Seoul (Immuncell-LC, Gemcitabine)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Seoul, Daehak-ro, Jongno-gu, Korea, Republic of
    Seoul National University Hospital
Nov 18, 2021

Pancreatic Cancer Trial in Pittsburgh (Gemcitabine, Capecitabine, Stereotactic Body Radiation Therapy (SBRT))

Completed
  • Pancreatic Cancer
  • Gemcitabine
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Cancer Centers
Feb 10, 2022

Unresectable Pancreatic Carcinoma Trial in Herlev, Oslo (Tocilizumab, Gemcitabine, nab-Paclitaxel)

Active, not recruiting
  • Unresectable Pancreatic Carcinoma
  • Herlev, Denmark
  • +1 more
Mar 15, 2022